13395_2019_218_MOESM11_ESM.pdf (11.05 kB)

MOESM11 of Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy

Download (11.05 kB)
journal contribution
posted on 13.12.2019, 07:39 by Cynthia Shu, Ariana Kaxon-Rupp, Judd Collado, Robert Damoiseaux, Rachelle Crosbie
Additional file 11: Table S5. Validation of hits from screen on hSSPN-EGFP myotubes. Initial hits from the screen were retested on hSSPN-EGFP myotubes at 5.5 μM in 2 plates (n = 24 per plate). R.U., relative units normalized to vehicle control. *SSMD, robust strictly standardized mean difference.


National Institute of Arthritis and Musculoskeletal and Skin Diseases